We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » PhRMA Rails Against House Drug Pricing Bill, Seeks Insurance Reform Instead
PhRMA Rails Against House Drug Pricing Bill, Seeks Insurance Reform Instead
The Pharmaceutical Research and Manufacturers of America (PhRMA) rolled out Eli Lilly CEO David Ricks and other prominent drug company executives yesterday to lobby against Congressional efforts to cut drug costs by allowing Medicare to negotiate prices.